Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 298 of 298 entries
View as:

Trial of Maintenance SUO11248 Versus Placebo Post Chemotherapy for Patients With Advanced Urothelial Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00393796 Org: User:
Start: 05/31/06 End: 12/31/12 Due: 12/31/13

Chemotherapy AND Bcl-xL Inhibitor (AT-101) For Organ Preservation In Adults With Advanced Laryngeal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01633541 Org: User:
Start: 03/31/12 End: 11/06/21 Due: 11/06/22

Surgical Treatment of Post-surgical Mastectomy Pain Utilizing the Regenerative Peripheral Nerve Interface

Phase: N/A Priority: Normal
NCT ID: NCT04530526 Org: User:
Start: 07/12/19 End: 09/30/23 Due: 09/30/24

Stem Cell Transplantation To Treat High Risk Multiple Myeloma With Reduced Toxicity Myeloablative Conditioning Regimen

Phase: N/A Priority: Normal
NCT ID: NCT00615589 Org: User:
Start: 02/29/08 End: 01/31/13 Due: 01/31/14

Effect of Pre-operative Virtual Visits on Patients With Head and Neck Cancer Undergoing Surgery

Phase: N/A Priority: Normal
NCT ID: NCT06094621 Org: User:
Start: 03/31/25 End: 06/30/26 Due: 06/30/27

A Pilot Study of Response-Driven Adaptive Radiation Therapy for Patients With Locally Advanced Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02492867 Org: User:
Start: 01/14/16 End: 04/21/22 Due: 04/21/23

MRI Study of Radiation-Induced Damage to White Matter and Blood-Brain-Barrier

Phase: N/A Priority: Normal
NCT ID: NCT01988675 Org: User:
Start: 08/26/04 End: 06/03/14 Due: 06/03/15

Optimizing Active Surveillance in Low-Risk Prostate Cancer: a Pilot Study

Phase: N/A Priority: Normal
NCT ID: NCT05764005 Org: User:
Start: 11/09/22 End: 03/11/24 Due: 03/11/25

Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen

Phase: N/A Priority: Normal
NCT ID: NCT00556452 Org: User:
Start: 10/31/07 End: 09/30/12 Due: 09/30/13

Feasibility Study of Evaluating Breast Cancer Patients With Ductal Lavage

Phase: N/A Priority: Normal
NCT ID: NCT00156260 Org: User:
Start: 01/31/03 End: 10/31/08 Due: 10/31/09

Early Imaging Biomarkers in NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT03121287 Org: User:
Start: 09/23/15 End: 01/31/19 Due: 01/31/20

Study of Combination Therapy With VELCADE, Doxil, and Dexamethasone (VDd) in Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00135187 Org: User:
Start: 07/31/04 End: 12/31/07 Due: 12/31/08

Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the Prostate

Phase: N/A Priority: Normal
NCT ID: NCT00151073 Org: User:
Start: 04/30/02 End: 09/30/07 Due: 09/30/08

A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy

Phase: N/A Priority: Normal
NCT ID: NCT06378398 Org: User:
Start: 06/14/24 End: 01/31/26 Due: 01/31/27

Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00176774 Org: User:
Start: 02/28/01 End: 04/30/04 Due: 04/30/05

Ipilimumab Induction in Patients With Melanoma Brain Metastases Receiving Stereotactic Radiosurgery

Phase: N/A Priority: Normal
NCT ID: NCT02097732 Org: User:
Start: 04/30/14 End: 07/31/20 Due: 07/31/21

Talazoparib in Combination With Belinostat for Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, and Metastatic Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04703920 Org: User:
Start: 03/04/21 End: 01/02/25 Due: 01/02/26

Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04396808 Org: User:
Start: 11/05/20 End: 07/31/25 Due: 07/31/26

Hepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial (HAMMER I)

Phase: N/A Priority: Normal
NCT ID: NCT05169957 Org: User:
Start: 08/09/22 End: 07/17/24 Due: 07/17/25

Study of Nivolumab in Combination With Gemcitabine/Cisplatin or Ipilimumab for Patients With Advanced Unresectable Biliary Tract Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03101566 Org: User:
Start: 09/08/17 End: 06/07/21 Due: 06/07/22

Feasibility of Virtual, Tailored, Music-Based Relaxation for Anxiety in Adolescent and Young Adult Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT05911269 Org: User:
Start: 01/21/25 End: 06/30/30 Due: 06/30/31

Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP)

Phase: N/A Priority: Normal
NCT ID: NCT06641310 Org: User:
Start: 06/01/25 End: 06/01/27 Due: 06/01/28

Aromatase Inhibitors in Premenopausal Breast Cancer Patients With Chemotherapy-Induced Ovarian Failure

Phase: N/A Priority: Normal
NCT ID: NCT00555477 Org: User:
Start: 08/31/07 End: 09/30/13 Due: 09/30/14